Senior Consultant Paediatric Cardiology
Paediatric & Congenital Heart Centre (PCHC)
Institut Jantung Negara (National Heart Institute)

Qualifications

1. MBBS, University of Queensland, Australia.
   December 1983
2. MRCP (UK), September 1988

Interest : Interventional Cardiology

Membership of Professional Bodies

1. Fellow of National Heart Association of Malaysia (NHAM)
2. Member of the Malaysian Paediatric Cardiac Society (MPCS)
3. Committee member of International Society of Invasive Cardiology

Editorial Boards

1. Associate Editor Paediatric Cardiology (2004 - 2006)
2. Editorial Board of Annals of Paediatric Cardiology (2008 - )
3. Faculty of 1000 Medicine - online reviewer of articles published in major journals in the field of paediatric cardiology (2007 - )
4. Congenital Cardiology Today

Dr. Teiji Akagi is Head, Professor of Adult Congenital Heart Disease Center, Okayama University Hospital, Okayama, Japan. He is the Vice President of Japanese Society of Adult Congenital Heart Disease. He graduated Kurume University, Kurume, Japan in 1984. He had research fellowship in division of cardiology, The Hospital for Sick Children, Toronto, Canada from 1989 to 92. Since 2004, he works in Cardiac Intensive Care Center, Okayama University Hospital, Okayama, Japan. His major is catheter intervention of congenital heart disease, adult congenital heart disease. He also has many important works about Kawasaki disease, pulmonary hypertension, cardiac imaging and hemodynamics.

Jae Young Choi is the Chief of the Division of Pediatric Cardiology and Director of the Center for Congenital Heart Disease at Severance Cardiovascular Hospital, Yonsei University, Seoul, Korea.

He received his graduate and post-graduate medical training, including M.D., M.S., and Ph.D., at Yonsei University.

He is a member of numerous medical societies, and on the editorial boards of the major national academic societies. Currently, he is the Chairman of Scientific Committee in the Korean Pediatric Heart Society and the Vice President of the Korean Society of Adult Congenital Heart Disease. He also serves as consultant to advisory committees of Korean government organizations. His major research interest is interventional treatment for congenital and structural heart diseases.

Consultant Pediatric Cardiologist
Glenmark Cardiac Centre
Nanavati Hospital, Mumbai
Breach Candy Hospital, Mumbai

M.D. (Int.Med.), D.M.(Cardiology)

FORMERLY
Asso. Prof. Of Cardiology
K.E.M. Hospital & Seth G.S.Medical College
Fellow in Pediatric Cardiology at Children's Hospital, Boston, U.S.A.
Hon. Registrar in Pediatric Cardiology at Hospital for Sick Children Great Ormond street, London, U.K.
Visiting Fellow, Pediatric Cardiology Cleveland Clinic, Ohio, U.S.A.

SCHOLARSHIPS AWARDS
Fulbright Scholar, 1997
International Medical Scholar of the Cleveland Clinic Foundation, 1997
Dr.P.N.Berry Scholar, 1994
International Medical Scholar of E.C.F.M.G., 1993

FELLOWSHIPS
Fellow of the American College of Cardiology

HONOURS
Past President of Pediatric Cardiac Society of India

PUBLICATIONS AND PRESENTATIONS
Founder Editor- in-chief: 'Annals of Pediatric Cardiology'
Editorial Board: Congenital Cardiology Today, Journal of Structural Heart Disease, Cardiology in the young (Member of the Committee on Mentorship)
Publications: more than hundred
Presentations: more than two hundred

Invited Faculty
Pediatric and Adult Interventional Cardiac Symposium (PICS~AICS) from 2004 to 2017
Cardiac Structural Interventions (CSI), Frankfurt from 2011 to 2017
Transcatheter Therapeutics Asia Pacific (TCTAP), Seoul from 2010 to 2017
Transcatheter Therapeutics (TCT), Washington, 2010 and 2014
A to Z Series, Ho Chi Minh City, Vietnam, 2011 to 2017
World Congress of Pediatric Cardiology and Cardiac Surgery, 2005, 2009, 2013
Asia Pacific Cardiac Interventional Symposium (APCIS), Seoul 2013, 2014, 2015, 2017
APCASH 2014, 2015, 2017

Orations
M. Vasa Oration awarded by Indian Medical Association, Vadodara, ( February 1996).
Dr M. P. Bhagat Oration awarded by the Staff Society at Seth G.S.Medical College and KEM Hospital, Mumbai on (August 17, 2009).
Mrs. Kanta Mujumdar Oration awarded by Cardiological Society of India, West Bengal chapter (Decemebr 2008).
Dr. U. K. Sheth Oration awarded by the Staff Society at Seth G.S.Medical College and KEM Hospital, Mumbai (January 21, 2011).
Dr K T Dholakia Oration awarded by the Western India Regional Orthopedic Conference (WIROC), Mumbai (Decemebr 2012).
Dr Ivan J Pinto Oration awarded by the Staff Society at Seth G.S.Medical College and KEM Hospital, Mumbai on (August 13, 2014).
Dr K G Deshpande Memorial Oration awarded by Cardiological Society of India, Vidarbha Chapter, Nagpur, (Septemebr 28, 2014)

Dr. Xavier Freixa is an Interventional Cardiologist at the Hospital Clinic of Barcelona, University of Barcelona. Dr. Freixa has been trained in interventional cardiology at the Toronto General Hospital, University Health Network and the Montreal Heart Institute, University of Montreal. He has a major interest in complex percutaneous coronary interventions, structural heart and adult congenital diseases. Among the main areas of interest highlight some advanced percutaneous techniques like PVL repair, left atrial appendage occlusion, ASD/VSD occlusion, TAVI and mitral valve repair with the Mitra-Clip system.

Dr Yun-Ching Fu graduated from National Yang-Ming University in Taipei, Taiwan in 1989. He was a general practitioner (1989-1993), pediatric resident (1993-1996) and cardiologic fellow (1996-1998) at Taipei Veterans General Hospital. He completed Ph.D. in the Institute of Clinical Medicine of National Yang-Ming University (2000-2003). He received interventional training in the University of Chicago Children's hospital under the instruction of Dr. Ziyad M. Hijazi (2004). He is currently the chief of Department of Pediatrics in Taichung Veterans General Hospital and the associate professor in National Yang-Ming universerty. He is interested in interventional therapy of congenital and structural heart diseases.

Chairman, Department of Pediatrics
Director, Sidra Cardiovascular Center of Excellence
Sidra Medical & Research Center
Past President, Society For Cardiovascular Angiography and Interventions (SCAI)

M.D., M.P.H., FACC, MSCAI, FAHA

Dr. Hijazi is an interventional cardiologist who specializes in treating congenital & structural heart disease in both children and adults. He is a pioneer in the non-surgical repair of congenital and structural heart defects.

After graduation from medical school and upon completion of his internship in Amman, Jordan, Dr. Hijazi came to the United States to begin postgraduate training in the Department of Epidemiology and Public Health at Yale University, where he was subsequently awarded a Masters of Public Health. He remained at Yale University where he completed a residency in Pediatrics and a fellowship in Pediatric Cardiology. Upon completion of his fellowship training, he joined the faculty at Tufts University School of Medicine as an Assistant Professor. In 1997 he was promoted to Associate Professor of Pediatrics and Medicine, and in 1999 Dr. Hijazi accepted faculty appointment at the University of Chicago as Endowed Professor of Pediatrics and Medicine and Chief of the division of cardiology. He has been successful in building a preeminent Pediatric Cardiology Program, which is nationally and internationally recognized for its outstanding clinical service and innovative technologies. In 2007 Dr. Hijazi became the Director of the Rush Center for Congenital and Structural Heart Disease at Rush University Medical Center and in 2010, he became the James A. Hunter, MD, University Chair.

His major area of interest is in the development of techniques and catheters/devices to help treat or cure congenital and structural cardiac disease without open-heart surgery. Dr. Hijazi is very prolific with more than 300 peer reviewed published articles, seven books and over 40 book chapters. In 1994 he published an article describing the technique of multiple coil closure of patent ductus arteriosus (PDA). His new technique enabled cardiologists to close moderate to large size PDAs using multiple coils. In 1997 he published the first results of the initial clinical use of the new Amplatzer septal occluder device for atrial septal defects (ASD)

Subsequently he has been a primary investigator in testing the Amplatzer family of intracardiac devices in the United States. Dr. Hijazi wrote the protocols for these trials and presented the results of these studies to the Food and Drug Administration. The trials have involved catheter closure of atrial septal defects, patent ductus arteriosus, patent foramen ovale (PFO) and ventricular septal defects. These studies resulted in the FDA approving the first ASD closure device for use in children in 2001. This study was published in the Journal of the American College of Cardiology in 2002.

His work has not been limited to the non-surgical repair of cardiac defects. Dr. Hijazi was the first to describe how intracardiac echocardiography (ICE) can be used to assist in guiding transcatheter closure of ASD/PFO.

His annual Pediatric & Adult Interventional Cardiac Symposium (PICS/AICS) is a four-day conference which brings together a select international faculty who provide demonstrations, live operations and the latest research breakthroughs in interventional cardiology for congenital & structural heart disease. This symposium attracts more than 750 interventional cardiologists from more than 60 countries around the world. Based upon this model, he is currently establishing collaborative pediatric cardiology research and clinical programs in China.

Currently, Dr. Hijazi is involved in evaluating percutaneous valve implantation (without surgery) for patients with defected pulmonary valves, senile aortic valve stenosis and leaky mitral valves. He performed the first operation (Pulmonary valve implantation) of its kind in the USA December 13th, 2005 on a 16-year old boy successfully.
In May 2013, he performed the first two pulmonary valve implantations using the new Venus P valve in China.
Further, he is currently involved with two companies to develop a percutaneous aortic valve for elderly patients with degenerative aortic valve stenosis.

On May 11th, 2008, Dr. Hijazi became the 31st president of the Society for Cardiovascular Angiography and Interventions (SCAI), the major organization for interventional cardiologists and has more than 4000 members worldwide.
In 2011, Mayor Thomas Menino declared July 24th, 2011 as the Ziyad M. Hijazi day in Boston, MA.
In January, Dr. Hijazi has become the 1st Chair of Pediatrics at Sidra Medical & Research Center, Doha-Qatar and Director, Sidra Cardiovascular Center of Excellence. In May 2014, Dr. Hijazi became the Acting Chief Medical Officer of Sidra Medical & Research Center, a role he completed in December 2015.
Also, in May 2014 he became a Master of the Society for Cardiovascular Angiography & Intervention (MSCAI), among the first class of recipients.

• Training in Internal Medicine and Cardiology (1994-2000) at University of Montreal, Montreal, Canada
• Training in Interventional Cardiology (2000-2002) at Montreal Heart Institute (University of Montreal, Montreal, Canada) and Brigham and Woman's Hospital (Harvard University, Boston, USA)
• Interventional Cardiologist at Montreal Heart Institute (Montreal, Canada) since 2002
• Director, Medical Intensive Care Unit (MICU) between 2006-2014
• Medical Director, Structural Heart Program since 2014
• Associate Professor at University of Montreal since 2010
• Professor of the year of the Department of Medicine (University of Montreal) in 2004 and 2005
• Personality of the week of La Presse newspaper (Montreal, Canada) in 2011
• Personality of the year - St-Hyacinthe College (St-Hyacinthe, Quebec, Canada) in 2012
• Accomplishment of many novelties including First-in-Man (FIM): Amplatzer Membranous Ventricular Septal Occluder II, Amplatzer Cardiac Plug (ACP) for left atrial appendage occlusion (LAAO)
• Examiner - Cardiology Boards of the Royal College of Canada since 2013
• International speaker and faculty at TCT (Transcatheter Cardiovascular Therapeutics) and EuroPCR (Paris Course on Revascularization) meetings
• Co-Director of several international meetings: Montreal Heart Summit in Montreal (Canada), LAA Summit in Europe, APCASH (Asia Pacific Congenital and Structural Heart intervention symposium) in Hong Kong (China)
• Proctor in structural interventions (transcatheter aortic valve replacement (TAVR), left atrial appendage occlusion (LAAO), complex congenital procedures)
• Clinical research in structural interventions (patent foramen ovale, left atrial appendage occlusion, congenital procedures, transcatheter aortic valve replacement) and atherosclerosis (progression-regression)
• Many peer-review publications
• Member of the Left Atrial Appendage Academic Research Consortium (LAAARC) and of the Paravalvar Leak Consortium (PVLARC)

Associate Professor of Medicine, Yonsei University Medical School
Director of the Hybrid Cathroom, Severance Cardiovascular Hospital
Massachusetts General Hospital

MD, PhD

Dr. Jung-sun Kim has completed his residency in medicine and fellowship in cardiology in Severance Hospital, Yonsei University and also successfully defended his doctorate thesis at the same university. His research interest has been intracoronary imaging, especially optical coherence tomography (OCT). For 10 years, he has pioneered the application of OCT to assess the coronary stent. He has a variety of experience for peripheral and aorta stent graft as well as coronary intervention. He has started Structural Heart Intervention including PMV, ASD, PFO and PDA since 2012 and expanded to LAA occlusion, paravalvular leakage and coronary fistula closure. He has been published over 40 SCI /SCIE papers as first or corresponding authors.

Dr Nguyen Lan Hieu is an adult and pediatric Cardiologist. He was granted Associate Professor in 2013. He is the Director of the Center of Cardiovascular Medicine, Hanoi Medical University Hospital; Vice Head of the Department of Cardiology, Hanoi Medical University. He has been in interventional practice for more than 20 years. He is a specialist in intervention of congenital and structural heart diseases. He is the Vietnamese interventionist with the highest number of congenital heart disease cases been intervened by himself through out Vietnam. His skillful hands are not only wellknown in his country but internationally. He has helped trained a large numbers of interventionists in his country and many countries throughout the world. He also travelled to many countries where the rate of congenital and structural heart diseases remained high to assisst doing intervention. He also helped his colleagues to fix difficult cases or cases with complication. He has attended and been a speaker in many conferences worldwide presenting topics related to interveniting congenital and structural heart diseases. Apart from doing intervention, he also had a lot of charity activities in screening children with congential heart diseases in various provinces in Vietnam, giving consultations and treating those children.

EDUCATION & PROFESSIONAL EXPERIENCE
Residency:
Internal Medicine
Sendai Kousei Hospital, Sendai, Miyagi, Japan
April 1. 2006 - March 31. 2008

Fellowship: Cardiovascular Medicine/Interventional Cardiology
Sendai Kousei Hospital, Sendai, Miyagi, Japan
April 1. 2008 - March 31. 2011

Physician: Cardiovascular Medicine/Interventional Cardiology
Division of Cardiology
Sendai Kousei Hospital, Sendai, Miyagi, Japan
April 1. 2011 - July 31. 2011

Visiting scientist: Interventional Cardiology
Cedars-Sinai Medical Center, Los Angeles, CA, USA
August 1. 2011 - July 31. 2014

Physician: Cardiovascular Medicine/Interventional Cardiology
Division of Cardiology
Sendai Kousei Hospital, Sendai, Miyagi, Japan
August 1. 2014 - September 30. 2015

Chief Physician: Cardiovascular Medicine/Interventional Cardiology
Division of Cardiology
Sendai Kousei Hospital, Sendai, Miyagi, Japan
October 1. 2015 - present.

PROFESSIONAL ACTIVITIES
Society membership:
Japanese Society of Internal Medicine
Japanese Circulation Society
Japanese Association of Cardiovascular Intervention and Therapeutics
Fellow of the Society for Cardiovascular Angiography and Interventions (FSCAI)
Fellow of the American College of Cardiology (FACC)

Title and/or degrees
M.D., FSCAI.
Assistant Professor

Current Position
Consultant, Pediatric Heart Center, Queen Sirikit National Institute of
Child Health (QSNICH), Bangkok, THAILAND
Board Committee, Society of Pediatric Cardiology of Thailand (SPCT)
Board Committee, Thai Resuscitation Council (TRC)

Education
Dr. Worakan Promphan graduated his Medical Degree with Second Class Honor from Prince of Songkla University in 1995 and then he pursued Pediatric Residency training at Songklanagarind Hospital, Thailand from 1995-1999. He was a Clinical Fellow in Pediatric Cardiology at Ramathibodi Hospital in 1999-2001 and was a Senior Clinical Fellow at Siriraj Hospital in 2002. He was a honorary visiting doctor at Evelina London Children's Hospital, UK in September 2008.

He has been working as a consultant of Pediatric Cardiology at QSNICH since 2006 mainly focusing on CHD and SHD Catheter Intervention. His clinical research interests are transcatheter therapy in various congenital heart lesions including the new system for percuteneous pulmonary valve implantation (PPVI) and long-term outcome of ASD device closure.

Consultant Cardiologist, Rigshospitalet, Copenhagen, Denmark
Professor of Cardiology, University of Copenhagen, Denmark

MD, DMSc

Dr. Lars Søndergaard trained in cardiology with special interest in congenital and structural heart diseases. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions. He has performed >1,000 TAVI procedures. PI for the NOTION I and NOTION II trial investigating TAVI vs. SAVR in younger, lower risk patients. He lead the first-in-human transcatheter mitral valve implantation in 2012.

Senior Consultant Department of Cardiology, NUHCS
Programme Director Congenital/Structural Heart Disease Programme, NUHCS
Assistant Professor Department of Medicine, Yong Loo Lin School of Medicine, NUS

Assistant Professor Edgar Tay is a practicing cardiologist at the National University Heart Centre, Singapore, and an assistant professor at the Yong Loo Lin School of Medicine, Singapore. Dr Tay obtained his Master of the Royal College of Physicians (UK) diploma in 2004, and completed his cardiology training at the National University Hospital, Singapore in 2008.

He obtained the Ministry of Health Scholarship to undergo sub-specialty training in adult congenital heart disease and pulmonary hypertension at the Royal Brompton Hospital, London, UK and then completed a second year of interventional fellowship at St Paul’s Hospital, Vancouver BC where he was trained in transcatheter aortic valve implantation. He now co-leads the TAVI and mitraclip mitral valve repair programme.

He has authored or co-authored numerous papers in peer-reviewed journals. He is accredited by the European Society of Echocardiography for adult congenital heart disease and has written book chapters on echocardiography in congenital heart disease and structural intervention.

Presently, he is actively involved in the management of patients with adult congenital heart disease, pulmonary hypertension and those with heart disease in pregnancy. He also sees patients with valvular heart disease who may benefit from transcatheter therapies.

Dr Apostolos Tzikas is an interventional cardiologist specialized in structural and congenital heart disease. He works at AHEPA University Hospital of Thessaloniki, Greece. He has a PhD from the Thoraxcenter, Rotterdam (supervised by Patrick W. Serruys) entitled "The role of advanced imaging in TAVI". He is an experienced clinical proctor for St Jude Medical in TAVI and LAA closure and he is responsible for the Amplatzer Cardiac Plug Registry, which has collected data on >1000 patient treated with in 22 centers worldwide.

Dr. Yin is Chief of the Division of Cardiology at the Cheng-Hsin General Hospital in Taipei and Associate Processor of Internal Medicine at the National Yang-Ming University, School of Medicine, Taipei, Taiwan. He is also the current Secretary General of the Taiwan Society of Cardiology, Councilor of the Asian Pacific Society of Cardiology, and the former President of the Taiwan Society of Lipids and Atherosclerosis.

After receiving a MD degree from the National Defense Medical Center, Dr. Yin trained in internal medicine and cardiology at Taipei Veterans General Hospital in Taipei. He conducted research for his PhD thesis at the National Yang-Ming University, School of Medicine, Taipei, Taiwan.

Dr. Yin is the Fellows of the European Society of Cardiology, the College of Asian Pacific Society of Cardiology, and the American Society of Angiology. He is also a member of the Heart Rhythm Society (North America) and Heart Failure Association (Europe). He is also a member of the Board of Directors of Taiwan Society of Cardiology, Taiwan Society of Cardiovascular Interventions, and Taiwan Society of Echocardiography.

His interests include interventional cardiology, management of patients with high risk for cardiovascular disease, and heart failures research. Dr. Yin has participated in many international clinical trials such as HOKUSAI-VTE (national PI), ROCKET-AF, ASEND-HF, etc., and has conducted many studies. He has published widely on topics in interventional cardiology, vascular biology, lipids, and hypertension in the Circulation Image, International Journal of Cardiology, American Heart Journal, European Journal of Clinical Investigation, European Journal of Heart Failure, PACE, Clinical Cardiology, Echocardiography, Acta Cardiologica, etc. He is also reviewers of the American Journal of Cardiology, Chinese Medical Journal (Taipei), and Acta Cardiologica Sinica.

He is a frequently invited lecturer on the topic of interventional cardiology, and cardiovascular risk and heart failure management. He is also a frequently invited faculty of interventional conferences, such as TCT (USA), TCT-AP (Korea), ENCORE (Korea), CCT (Japan), TOPIC (Japan), CIT, CHC, GWICC (China), APCC, APSIC, AsiaPCR/SingLive (Singapore), etc.

Interventional cardiologist
Fiona Stanley Hospital
Royal Perth Hospital

Dr. Gerald Yong trained at Royal Perth Hospital, Northwestern University Chicago and Montreal Heart Institute concentrating on coronary and structural interventions. He set up the service to deliver transcatheter aortic valve replacement (TAVI) in Western Australia. He is the head of the Western Australian High Risk Aortic Stenosis Service / TAVI program, and the Director of Structural Intervention at Fiona Stanley Hospital. He has proctored TAVI nationally and internationally, and has been an invited speaker on this area in multiple international conferences.